missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Mouse S100A8/S100A9 Heterodimer Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 8916-S8-050
404.31 EUR valid until 2024-12-16
Use promo code "21630" to get your promotional price.
This item is not returnable.
View return policy
Description
The Recombinant Mouse S100A8/S100A9 Heterodimer Protein is derived from E. coli. The Recombinant Mouse S100A8/S100A9 Heterodimer Protein has been validated for the following applications: Bioactivity.Specifications
| Bioactivity | |
| 50 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| S100A8/S100A9 Heterodimer | |
| Unconjugated | |
| Recombinant | |
| >95%, by SDS-PAGE with Silver Staining |
| Observed M.W.: 7kDa and 12kDa, reducing conditions, Theoretical M.W.: 10kDa (S100A8), 13kDa (S100A9) | |
| E. coli-derived mouse S100A8/S100A9 Heterodimer protein, (N-terminus) Mouse S100A8 (Pro2-Glu89) Accession &Num; P27005 Mouse S100A9 (Ala2-Lys113) Accession &Num; P31725 (C-terminus) | |
| <0.10 EU per 1μg of the protein by the LAL method. | |
| Measured by its ability to induce IL-6 secretion by A375 human melanoma cells. Hibino, T. et al. (2013) Cancer Res. 73:172. The ED50 for this effect is typically 1.5-6μg/mL. | |
| Mouse | |
| E. coli-derived Mouse S100A8 (Pro2-Glu89) Accession # P27005, N-terminal; Mouse S100A9 (Ala2-Lys113) Accession # P31725, C-terminus |